SGHT(Sight Sciences, Inc.) · 财务报表

SGHT(Sight Sciences, Inc.) 的财务报表:医疗保健,医疗器械。数据来自 SEC 公开申报与市场行情,不构成投资建议。

近年年度财务(SEC XBRL)
科目FY 截至 2021-12-31FY 截至 2022-12-31FY 截至 2023-12-31FY 截至 2024-12-31FY 截至 2025-12-31
营业收入$48.96M$71.33M$81.06M$79.87M$77.36M
毛利润$40.35M$58.97M$69.17M$68.28M$66.67M
营业利润−$51.48M−$83.95M−$57.27M−$50.53M−$37.10M
净利润−$62.96M−$86.24M−$55.55M−$51.51M−$38.43M
经营现金流−$52.54M−$75.97M−$47.18M−$22.35M−$29.69M
自由现金流−$53.35M−$76.94M−$47.98M−$22.74M−$29.92M
摊薄每股收益$-2.36$-1.80$-1.14$-1.03$-0.74

Sight Sciences, Inc. SGHT